CAJ | 학술논문

目的：观察足三里穴位注射新斯的明对腹腔镜胆囊切术后患者胃肠功能的影响。方法：将120例腹腔镜胆囊切除术患者根据随机数字按照1：1：1比例分为穴位注射组、肌肉注射组及空白对照组,每组40例。空白对照组给予术后常规治疗,穴位注射组在常规治疗基础上加用双侧足三里穴位注射新斯的明注射液2 mL,肌肉注射组在常规治疗基础上加用肌肉注射新斯的明注射液2 mL。两组均每日治疗2次,最多治疗3 d。观察三组患者术后肠鸣音恢复时间、肛门首次排气时间、排便时间及临床疗效。结果：治疗后,三组患者术后肠鸣音恢复时间比较,差异具有统计学意义(F＝17.30, P＜0.05),穴位注射组、肌肉注射组与空白对照组差异均有统计学意义(P＜0.05),穴位注射组与肌肉注射组差异有统计学意义(P＜0.05)；三组患者术后肛门首次排气时间比较,差异具有统计学意义(F＝19.12, P＜0.05),穴位注射组与肌肉注射组及空白对照组差异具有统计学意义(P＜0.05)；三组患者术后首次排便时间比较,三组差异具有统计学意义(χ2＝21.23, P＜0.05),穴位注射组与肌肉注射组差异无统计学意义(P＞0.05)。穴位注射组总有效率为87.5%,肌肉注射组为72.5%,空白对照组有效率为60.0%,三组总有效率差异具有统计学意义(P＜0.05)。结论：足三里穴位注射新斯的明能够缩短腹腔镜胆囊切除术患者术后肠鸣音恢复时间及肛门排气时间,其效果优于肌肉注射新斯的明。
목적：관찰족삼리혈위주사신사적명대복강경담낭절술후환자위장공능적영향。방법：장120례복강경담낭절제술환자근거수궤수자안조1：1：1비례분위혈위주사조、기육주사조급공백대조조,매조40례。공백대조조급여술후상규치료,혈위주사조재상규치료기출상가용쌍측족삼리혈위주사신사적명주사액2 mL,기육주사조재상규치료기출상가용기육주사신사적명주사액2 mL。량조균매일치료2차,최다치료3 d。관찰삼조환자술후장명음회복시간、항문수차배기시간、배편시간급림상료효。결과：치료후,삼조환자술후장명음회복시간비교,차이구유통계학의의(F＝17.30, P＜0.05),혈위주사조、기육주사조여공백대조조차이균유통계학의의(P＜0.05),혈위주사조여기육주사조차이유통계학의의(P＜0.05)；삼조환자술후항문수차배기시간비교,차이구유통계학의의(F＝19.12, P＜0.05),혈위주사조여기육주사조급공백대조조차이구유통계학의의(P＜0.05)；삼조환자술후수차배편시간비교,삼조차이구유통계학의의(χ2＝21.23, P＜0.05),혈위주사조여기육주사조차이무통계학의의(P＞0.05)。혈위주사조총유효솔위87.5%,기육주사조위72.5%,공백대조조유효솔위60.0%,삼조총유효솔차이구유통계학의의(P＜0.05)。결론：족삼리혈위주사신사적명능구축단복강경담낭절제술환자술후장명음회복시간급항문배기시간,기효과우우기육주사신사적명。
Objective:To observe the effect of acupoint injection with Neostigmine Methylsulfate at Zusanli (ST 36) on gastrointestinal function of patients after laparoscopic cholecystectomy. Methods:Totally 120 patients undergone laparoscopic cholecystectomy were randomized into an acupoint injection group, a muscular injection group, and a blank control group at 1:1:1 by random number table, 40 cases in each group. The blank control group was intervened by conventional post-operation treatment, the acupoint injection group was by acupoint injection with Neostigmine Methylsulfate 2 mL at bilateral Zusanli (ST 36) in addition to the treatment given to the blank control group, and the muscular injection group was by muscular injection with Neostigmine Methylsulfate 2 mL in addition to the treatment given to the blank control group. The two injection groups both received injection twice a day, totally for 3 d at most. The restored time of bowel sounds, initial flatulence time, defecation time and clinical efficacy were observed. Results:After treatment, there were significant differences in comparing the restored time of bowel sounds among the three groups (F=17.30,P<0.05), the acupoint injection group and muscular injection group were significantly different from the blank control group (P<0.05), and there was a significant difference between the acupoint injection group and muscular injection group (P<0.05); there were significant differences in comparing the initial flatulence time among the three groups (F=19.12,P<0.05), and the acupoint injection group was significantly different from the muscular injection group and the blank control group (P<0.05); there were significant differences in comparing the initial defecation time among the three groups (χ2=21.23,P<0.05), while the difference between the acupoint injection group and muscular injection group was statistically insignificant (P>0.05). The total effective rate was 87.5% in the acupoint injection group, versus 72.5% in the muscular injection group and 60.0% in the blank control group, and there were significant differences among the three groups (P<0.05). Conclusion:Acupoint injection with Neostigmine Methylsulfate at Zusanli (ST 36) can shorten the restored time of bowel sounds and flatulence time in patients undergone laparoscopic cholecystectomy, and the efficacy is more significant compared to muscular injection with Neostigmine Methylsulfate.